Treatment of Acquired Hemophilia A (AHA) with Rituximab (R): Clinical Outcomes and Cost of Hemostatic Agents

被引：0
|
作者：
Roengvoraphoj, Monic [1 ]
Jensen, Eleanor R. [1 ]
Mckernan, Laurel [1 ]
Briggs, Anna [1 ]
Ornstein, Deborah L. [2 ,3 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
[2] Dartmouth Med Sch, Dept Pathol, Lebanon, NH USA
[3] Dartmouth Med Sch, Dept Med, Lebanon, NH USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1358 / 1358
页数：1
相关论文
共 50 条
  • [41] New option of hemostatic treatment for acquired hemophilia A by single injection of emicizumab, FVIIIa mimicking bispecific antibody, irrespective of epitope specificity
    Takeyama, Masahiro
    HAEMOPHILIA, 2018, 24 : 12 - 12
  • [42] Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors-A Single-Center, Pilot Study
    Chaireti, Roza
    Soutari, Nida
    Holmstrom, Margareta
    Petrini, Pia
    Magnusson, Maria
    Ranta, Susanna
    Pruner, Iva
    Antovic, Jovan P.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [43] A single center clinical survey on the treatment of 24 cases of acquired hemophilia A: a 2011 update
    Kyoichi, O.
    Suzuki, T.
    Otaki, M.
    Seita, I
    Muramatsu, T.
    Yotsumoto, M.
    Hagiwara, T.
    Amano, K.
    Fukutake, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 806 - 806
  • [44] Case Series: Outcome and Cost Analysis of Rituximab Versus Non-Targeted Immunosuppression As First Line Inhibitor Eradication in Acquired Hemophilia a
    Cusano, Ellen
    Lee, Adrienne
    Hews-Girard, Julia
    BLOOD, 2019, 134
  • [45] Orihime Study: Real World Treatment Patterns and Clinical Outcomes of 338 Patients with Acquired Hemophilia a from a Japanese Health Claims Database
    Ogawa, Yoshiyuki
    Amano, Kagehiro
    Matsuo-Tezuka, Yukari
    Okada, Norihiro
    Murakami, Yoichi
    Nakamura, Takao
    Yamaguchi-Suita, Haruko
    Nogami, Keiji
    BLOOD, 2021, 138
  • [46] ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database
    Yoshiyuki Ogawa
    Kagehiro Amano
    Yukari Matsuo-Tezuka
    Norihiro Okada
    Yoichi Murakami
    Takao Nakamura
    Haruko Yamaguchi-Suita
    Keiji Nogami
    International Journal of Hematology, 2023, 117 : 44 - 55
  • [47] ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database
    Ogawa, Yoshiyuki
    Amano, Kagehiro
    Matsuo-Tezuka, Yukari
    Okada, Norihiro
    Murakami, Yoichi
    Nakamura, Takao
    Yamaguchi-Suita, Haruko
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 44 - 55
  • [48] The Etiologic Agents and Clinical Outcomes of Adult Community-acquired Pneumonia in Jeju
    Jeon, Bong-Hee
    Kim, Miok
    Kim, Jeong Hong
    Shin, Sang Yop
    Lee, Jaechun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (05) : 358 - 364
  • [49] aPCC vs. rFVIIa for the Treatment of Bleeding in Patients with Acquired Hemophilia - a Cost-Effectiveness Analysis
    Kim, Chong H.
    Simmons, Sierra C.
    Bui, Chau M.
    Jiang, Ning
    Pham, Huy P.
    TRANSFUSION, 2018, 58 : 165A - 165A
  • [50] Clinical outcomes and cost of outpatient community-based treatment for rituximab refractory non-Hodgkins Lymphoma (NHL) patients
    Zelenetz, AD
    Tang, BX
    Frame, D
    Nalysnyk, L
    Cella, C
    Noel, JK
    BLOOD, 2004, 104 (11) : 856A - 856A
12345